scispace - formally typeset
W

William J. Elliott

Researcher at Pacific Northwest University of Health Sciences

Publications -  219
Citations -  13758

William J. Elliott is an academic researcher from Pacific Northwest University of Health Sciences. The author has contributed to research in topics: Blood pressure & Clinical trial. The author has an hindex of 51, co-authored 216 publications receiving 13146 citations. Previous affiliations of William J. Elliott include University of Chicago & Rush University.

Papers
More filters
Journal ArticleDOI

Preserving renal function in adults with hypertension and diabetes: A consensus approach

TL;DR: An evidence-based approach is provided, integrating data from the major clinical trials that were designed as randomized prospective, long-term studies that had as a primary endpoint either progression of diabetic nephropathy or reduction in CV events to achieve lower blood pressure goals.
Journal ArticleDOI

Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis

TL;DR: The association of antihypertensive drugs with incident diabetes is therefore lowest for ARB and ACE inhibitors followed by CCB and placebo, beta blockers and diuretics in rank order.
Journal ArticleDOI

Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.

TL;DR: The CONVINCE trial did not demonstrate equivalence of a COER verapamil–based antihypertensive regimen compared with a regimen beginning with a diuretic or -blocker, and data indicate that the effectiveness of calcium-channel therapy in reducing cardiovascular disease is similar but not better than diuresis treatment.
Journal ArticleDOI

Circadian Variation in the Timing of Stroke Onset A Meta-analysis

TL;DR: These data support the presence of a circadian pattern in the onset of stroke, with a significantly higher risk in the morning.
Journal ArticleDOI

Resistant Hypertension: Diagnosis, Evaluation, and Treatment: A Scientific Statement From the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research

TL;DR: Expanding the understanding of the causes of resistant hypertension and thereby potentially allowing for more effective prevention and/or treatment will be essential to improve the long-term clinical management of this disorder.